- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD27, also known as TNF receptor superfamily member 7 (TNFRSF7), is a type I transmembrane receptor expressed on T lymphocytes, memory B cells, and subsets of natural killer cells, where it regulates immune activation, survival, and differentiation. CD27 Antibody / Protein Microarray Specificity Validated Antibody (clone LPFS2/4177) is uniquely positioned for applications requiring well-characterized binding specificity, supported by protein microarray-based validation against a broad panel of recombinant proteins. CD27 antibody reagents are widely used in immunology and cell signaling studies, where accurate target recognition is essential for reliable interpretation of experimental data.
CD27 antibody, also referred to as TNFRSF7 antibody or CD27 immune receptor antibody in the literature, belongs to a class of targets within the TNF receptor superfamily that share structural features and conserved domains. This structural similarity increases the importance of specificity validation, as off-target recognition of related receptors can lead to ambiguous results. Protein microarray validation provides a systematic approach to evaluating antibody binding across diverse protein targets, helping confirm selective recognition of CD27 under controlled conditions.
CD27 Antibody / Protein Microarray Specificity Validated Antibody (clone LPFS2/4177) demonstrates selective binding to CD27 in microarray-based screening, supporting its use in experiments where cross-reactivity must be minimized. Protein microarrays enable parallel interrogation of antibody binding across large protein panels, providing a broad assessment of specificity that extends beyond single-target validation approaches. This makes them particularly useful for identifying potential off-target interactions and confirming antibody selectivity at scale.
In biological samples, CD27 is expressed in immune cell populations with dynamic activation states and undergoes post-translational processing, including glycosylation. These features can complicate detection if antibodies exhibit non-specific binding. Validation using protein microarrays helps ensure that observed signals correspond to CD27 rather than structurally related or co-expressed proteins, improving confidence in downstream analyses.
The mouse monoclonal clone LPFS2/4177 antibody is designed to provide consistent and reproducible detection of CD27, with specificity supported by protein microarray screening. This validation approach is particularly valuable for applications involving complex lysates, multiplexed assays, or exploratory studies where distinguishing true signal from background is critical.
Overall, CD27 Antibody / Protein Microarray Specificity Validated Antibody (clone LPFS2/4177) provides reliable detection of CD27 with demonstrated selectivity across a broad protein panel, supporting its use in research applications that require strong specificity and confidence in target recognition.
This antibody is part of a broader CD27 antibody collection designed to support diverse immunological research applications.
Optimal dilution of the CD27 Antibody / Protein Microarray Specificity Validated Antibody should be determined by the researcher.
A portion of amino acids 28-170 from the human protein was used as the immunogen for the CD27 antibody.
Store the CD27 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
TNFRSF7 antibody, CD27 protein microarray validated antibody, CD27 specificity validated antibody, CD27 immune receptor antibody, CD27 monoclonal antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.